NeoVax

Business Data, Corporate Office and Headquarter Address

About

NeoVax is Drug Discovery in United States that focus on developer business. They cover business area such as developer, vaccine, several infectious disease.

Business Type

Drug Discovery

Country

United States

Founded

-

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

6812 Idylwild
Boulder, CO 80301
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developervaccineseveral infectious disease

* We use standard office opening hours in near NeoVax's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

NeoVax Frequently Asked Questions

What or who is NeoVax?

NeoVax is Drug Discovery business from United States that founded in - ( years old in ), NeoVax business is focusing on Developer.

Where is NeoVax headquarter and corporate office address?

NeoVax headquarter office and corporate office address is located in 6812 Idylwild Boulder, CO 80301 United States.

Where is NeoVax country origins?

NeoVax was founded in United States.

What is Developer business focus on?

In , NeoVax is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with NeoVax, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.